Search - tctmd.com

Displaying 141 - 160 of 651

Sort: Relevancy | Date

Presentation NY Valves 2024

Challenges With Vulnerable, Underrepresented Populations

Presenter: Clyde W. Yancy

June 06, 2024

Presentation NY Valves 2024

Trialist Perspective

Presenter: Roxana Mehran

June 06, 2024

Presentation NY Valves 2024

Industry Perspective

Presenter: Janarthanan Sathananthan

June 06, 2024

Presentation NY Valves 2024

FDA Perspective

Presenter: Lisa Plummer

June 06, 2024

Presentation NY Valves 2024

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Presenter: Donna Mancini

June 05, 2024

Presentation NY Valves 2024

Medical Management Post AVR

Presenter: Javed Butler

June 05, 2024

Presentation NY Valves 2024

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Presenter: Parag Goyal

June 05, 2024

Presentation NY Valves 2024

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Presenter: Kyle R. Lehenbauer

June 05, 2024

Presentation NY Valves 2024

Current and Future use of Artificial Intelligence in Echocardiography

Presenter: Akhil Narang

June 05, 2024

Presentation NY Valves 2024

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Presenter: Madalina Garbi

June 05, 2024

Presentation NY Valves 2024

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

Presenter: Elad Maor

June 05, 2024

Presentation NY Valves 2024

Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD

Presenter: Omar K. Khalique

June 05, 2024

Presentation NY Valves 2024

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

Presenter: Partho P. Sengupta

June 05, 2024

Presentation NY Valves 2024

Overview of the Role of Artificial Intelligence and Machine Learning for VHD Detection

Presenter: Timothy Joseph Poterucha

June 05, 2024

Presentation NY Valves 2024

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Presenter: Paul A. Grayburn

June 05, 2024

Presentation NY Valves 2024

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Presenter: Anjali Sharma

June 05, 2024

Presentation NY Valves 2024

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

Presenter: Marie-Annick Clavel

June 05, 2024

News Daily News

Potential Contributors to ESUS Explored in New Consensus Statement

Todd Neale

May 14, 2024

News Conference News SCAI 2024

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

L.A. McKeown

May 07, 2024

News Daily News

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Michael O'Riordan

May 06, 2024

Advertisement

Challenges With Vulnerable, Underrepresented Populations

Trialist Perspective

Industry Perspective

FDA Perspective

Secondary MR and GDMT Titration Before M-TEER in the Real-world

Medical Management Post AVR

Requirements for GDMT in UPSTREAM AVR Clinical Trials in (1) Preserved EF or (2) Reduced EF Patients

Case Presentation: Aortic Stenosis and Dyspnea – What Do We Call It? Is It HFpEF OR Is It the Valve?

Current and Future use of Artificial Intelligence in Echocardiography

Echocardiographic Speckle Strain Imaging and Valvular Heart Disease Outcomes

Revolutionizing Valvular Disease Diagnosis: Empowering Non-Cardiology Practitioners With AI-Augmented POCUS

Unleashing the Potential of CMR and CT: Myocardial Risk Stratification for VHD

Keynote Lecture: AI-Powered Multimodality Cardiac Imaging in Valvular Heart Disease: From Screening to Intervention

Overview of the Role of Artificial Intelligence and Machine Learning for VHD Detection

Mitral Regurgitation Quantitation: Are Different Methods Required for Primary vs Secondary Disease?

Assessing Severity of Mixed Valve Disease Based on Multi-Modality Imaging and Echo Hemodynamics

Paradoxical Low-Flow, Low-Gradient AS: Diagnosis and Management based on Multi-Modality Imaging

Potential Contributors to ESUS Explored in New Consensus Statement

PCI and TAVI Safe, Even When Done at the Same Time: TVT Registry

TAVI Outcomes Linked to LV Recovery in Patients With Severe Dysfunction

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content